The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACUTUS MEDICAL INC | COM | 005111109 | 10,188 | 599,990 | SH | SOLE | 599,990 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 8,821 | 1,670,600 | SH | SOLE | 1,670,600 | 0 | 0 | ||
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 3,254 | 980,000 | SH | SOLE | 980,000 | 0 | 0 | ||
AVEO BIOSCIENCES INC | COM NEW | 053588307 | 4,264 | 647,000 | SH | SOLE | 647,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADS | 09071M205 | 47 | 16,667 | SH | SOLE | 16,667 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 31,525 | 517,150 | SH | SOLE | 517,150 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 3,079 | 463,000 | SH | SOLE | 463,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 32,938 | 985,000 | SH | SOLE | 985,000 | 0 | 0 | ||
CERECOR INC | COM | 15671L109 | 5,126 | 1,567,494 | SH | SOLE | 1,567,494 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 37,040 | 4,630,000 | SH | SOLE | 4,630,000 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 148 | 73,351 | SH | SOLE | 73,351 | 0 | 0 | ||
CM LIFE SCIENCES INC | COM CL A | 18978W109 | 5,237 | 373,828 | SH | SOLE | 373,828 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 30,478 | 1,345,000 | SH | SOLE | 1,345,000 | 0 | 0 | ||
CONTRAFECT CORP | COM NEW | 212326300 | 255 | 57,900 | SH | SOLE | 57,900 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 3,779 | 200,500 | SH | SOLE | 200,500 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 11,478 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 7,519 | 205,381 | SH | SOLE | 205,381 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 8,115 | 284,050 | SH | SOLE | 284,050 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 29,310 | 3,692,600 | SH | SOLE | 3,692,600 | 0 | 0 | ||
FORMA THERAPEUTICS HOLDINGS INC | SHS | 34633R104 | 4,256 | 171,000 | SH | SOLE | 171,000 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 34960Q109 | 13,834 | 3,875,000 | SH | SOLE | 3,875,000 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 29,171 | 3,140,000 | SH | SOLE | 3,140,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 9,980 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 3,789 | 697,800 | SH | SOLE | 697,800 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 16,092 | 1,155,200 | SH | SOLE | 1,155,200 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 7,147 | 727,800 | SH | SOLE | 727,800 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 886 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | ||
LUMOS PHARMA INC | COM | 55028X109 | 3,820 | 382,000 | SH | SOLE | 382,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 15,529 | 578,150 | SH | SOLE | 578,150 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 4,460 | 1,565,000 | SH | SOLE | 1,565,000 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 10,672 | 1,156,200 | SH | SOLE | 1,156,200 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 91,886 | 6,480,000 | SH | SOLE | 6,480,000 | 0 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 3,815 | 1,226,600 | SH | SOLE | 1,226,600 | 0 | 0 | ||
PHARVARIS NV | COM | N69605108 | 1,487 | 79,837 | SH | SOLE | 79,837 | 0 | 0 | ||
PROQR THERAPEUTICS NV | SHS EURO | N71542109 | 9,304 | 1,380,400 | SH | SOLE | 1,380,400 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 14,820 | 330,222 | SH | SOLE | 330,222 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 24,920 | 2,558,472 | SH | SOLE | 2,558,472 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | 5,963 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 3,222 | 165,500 | SH | SOLE | 165,500 | 0 | 0 | ||
SIO GENE THERAPIES INC | COMMON | 829399104 | 5,258 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 24,355 | 2,526,500 | SH | SOLE | 2,526,500 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 9,237 | 496,900 | SH | SOLE | 496,900 | 0 | 0 | ||
TELA BIO INC | COM | 872381108 | 7,096 | 440,465 | SH | SOLE | 440,465 | 0 | 0 | ||
TRACON PHARMACEUTICALS INC | COM NEW | 89237H209 | 16,344 | 2,518,371 | SH | SOLE | 2,518,371 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 8,054 | 357,800 | SH | SOLE | 357,800 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 9,463 | 2,325,000 | SH | SOLE | 2,325,000 | 0 | 0 | ||
VIRACTA THERAPEUTICS INC | COM | 92765F108 | 2,917 | 257,189 | SH | SOLE | 257,189 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 11,682 | 343,600 | SH | SOLE | 343,600 | 0 | 0 |